Dysport Therapeutic · DIN 02460203 · 300U/Vial · Pd injection-vial
Limited Use, Reason for Use code 130, 412, 413 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 130, 412, 413 required
Write on scriptone applicable Reason for Use code, 130 or 412 or 413 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 130, 412, 413
Coverage limit:
Dysport Therapeutic should be administered personally by a neurologist, pediatrician, or a physician with equivalent post-graduate training and experience with neuromuscular disorders.
Reason for Use code 130
To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 412
For the management of focal spasticity, due to stroke or spinal cord injury in adults.
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 413
For the treatment of focal spasticity secondary to cerebral palsy in patients two years of age or older.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Dysport Therapeutic · DIN 02460203
Manufacturer: Ipsen Limited; listing date 2018-09-27
Health Canada: Marketed since 2022-04-06 · brand DYSPORT THERAPEUTIC · ATC M03AX01 BOTULINUM TOXIN · form Powder for solution · route Intramuscular · ingredients ABOBOTULINUMTOXINA 300 UNIT/VIAL · company Ipsen biopharmaceuticals canada inc · schedule Schedule d, Prescription
Dysport Therapeutic: Formulary list price $385.56 per unit (the source does not state the unit; exact figure $385.5600). What the ministry pays, not the patient.
Ministry pays: $385.5600 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02460203)
Source record
DIN 02460203: Dysport Therapeutic
Raw flags: sec12=Y, sec3=Y
Item: 929200001; group id 1052; item number 2410; lccId 00308; manufacturer id IPS
Source form: Pd Inj-Vial Pk; strength: 300U/Vial
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $385.5600; ministry $385.5600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02460203
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94749
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02460203
Shortage record checked October 6, 2026